Page last updated: 2024-11-05

zonisamide and Myelopathy

zonisamide has been researched along with Myelopathy in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Degenerative cervical myelopathy (DCM) is a severe condition of the spinal cord caused by chronic compression."5.91Zonisamide improves Fas/FasL-mediated apoptosis and inflammation in a degenerative cervical myelopathy rat model. ( Tan, Y; Wang, Z; Xu, F, 2023)
"Cervical spondylotic myelopathy (CSM) is caused by chronic compression of the spinal cord and is the most common cause of myelopathy in adults."5.56Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model. ( Imagama, S; Inoue, T; Ishiguro, N; Ito, M; Kanbara, S; Koshimizu, H; Masuda, A; Nakashima, H; Ohkawara, B; Ohno, K; Ohta, K; Tomita, H, 2020)
"Degenerative cervical myelopathy (DCM) is a severe condition of the spinal cord caused by chronic compression."1.91Zonisamide improves Fas/FasL-mediated apoptosis and inflammation in a degenerative cervical myelopathy rat model. ( Tan, Y; Wang, Z; Xu, F, 2023)
"Cervical spondylotic myelopathy (CSM) is caused by chronic compression of the spinal cord and is the most common cause of myelopathy in adults."1.56Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model. ( Imagama, S; Inoue, T; Ishiguro, N; Ito, M; Kanbara, S; Koshimizu, H; Masuda, A; Nakashima, H; Ohkawara, B; Ohno, K; Ohta, K; Tomita, H, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Wang, Z1
Tan, Y1
Xu, F1
Kanbara, S1
Ohkawara, B1
Nakashima, H1
Ohta, K1
Koshimizu, H1
Inoue, T1
Tomita, H1
Ito, M1
Masuda, A1
Ishiguro, N1
Imagama, S1
Ohno, K1

Other Studies

2 other studies available for zonisamide and Myelopathy

ArticleYear
Zonisamide improves Fas/FasL-mediated apoptosis and inflammation in a degenerative cervical myelopathy rat model.
    Tissue & cell, 2023, Volume: 81

    Topics: Animals; Apoptosis; Caspase 10; Caspase 3; Caspase 8; Caspase 9; Fas Ligand Protein; Inflammation; P

2023
Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model.
    Scientific reports, 2020, 08-04, Volume: 10, Issue:1

    Topics: Animals; Cervical Vertebrae; Disease Models, Animal; Disease Progression; Female; Motor Neurons; Rat

2020